Propylene Glycol

Propylene Glycol

SCHEMBL8832136

CC(O)CO.NC(N)=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylene Glycol SCHEMBL8730890 0.94 TDP1 (0.59)
Propylene Glycol SCHEMBL27548540 0.90
Propylene Glycol SCHEMBL7708272 0.90
Lactic Acid SCHEMBL3058015 0.89 TP53 (0.58)
Propylene Glycol SCHEMBL28527603 0.89 TDP1 (0.53)
Propylene Glycol SCHEMBL8562905 0.88 TDP1 (0.59)
Propylene Glycol SCHEMBL9016119 0.88 TDP1 (0.59)
Glycerin SCHEMBL8734337 0.87 TDP1 (0.50)
Propylene Glycol SCHEMBL8031321 0.86
Glycerin SCHEMBL11848316 0.84 TDP1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130256228-A1 USE OF NOVEL DRAW SOLUTES AND COMBINATIONS THEREOF TO IMPROVE PERFORMANCE OF A FORWARD OSMOSIS SYSTEM AND PROCESS HYDRATION SYSTEMS, LLC 2013-10-03 US claimed
WO-2013148289-A1 USE OF NOVEL DRAW SOLUTES AND COMBINATIONS IN FORWARD OSMOSIS SYSTEM HYDRATION SYSTEMS, LLC (US) 2013-10-03 WO claimed
CN-112336706-A Veterinary amitraz solution synergist and preparation method thereof 江苏南京农大动物药业有限公司 2021-02-09 CN disclosed
CN-106038330-B A kind of mildy wash and preparation method thereof 杭州兰茜化妆品有限公司 2019-04-02 CN disclosed
CN-109280043-A Method and device for manufacturing propylene carbonate and dimethyl carbonate 王圣洁 2019-01-29 CN disclosed
US-20180338964-A1 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS EMERITI PHARMA AB (SE) 2018-11-29 US disclosed
US-20170360766-A1 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS EMERITI PHARMA AB (SE) 2017-12-21 US disclosed
EP-3233189-A1 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(2H)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS Emeriti Pharma AB (SE) 2017-10-25 EP disclosed
CN-106038330-A Facial cleanser and preparation method thereof 杭州兰茜化妆品有限公司 2016-10-26 CN disclosed
WO-2016099397-A1 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(2H)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS EMERITI PHARMA AB (SE) 2016-06-23 WO disclosed
US-20140193876-A1 METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN GOERKE AARON R (US) 2014-07-10 US disclosed
US-20130256228-A1 USE OF NOVEL DRAW SOLUTES AND COMBINATIONS THEREOF TO IMPROVE PERFORMANCE OF A FORWARD OSMOSIS SYSTEM AND PROCESS HYDRATION SYSTEMS, LLC 2013-10-03 US disclosed
WO-2013148289-A1 USE OF NOVEL DRAW SOLUTES AND COMBINATIONS IN FORWARD OSMOSIS SYSTEM HYDRATION SYSTEMS, LLC (US) 2013-10-03 WO disclosed
WO-2012173876-A1 METHODS OF PURIFICATION OF NATIVE OR MUTANT FORMS OF DIPHTHERIA TOXIN MERCK SHARP & DOHME CORP. (US) 2012-12-20 WO disclosed
US-5653839-A FILLING SPACE BETWEEN TWO PLATES OF SILANE-TREATED VITREOUS MATERIAL WITH ACRYLAMIDE DERIVATIVE AND ADDITIVES, POLYMERIZING MITSUI TOATSU CHEMICAL INCORPORATED (JP) 1997-08-05 US disclosed
US-5525635-A APPLYING MIXTURE FOR SKIN AND FINGERNAIL DISORDERS MOBERG DERMA AB (SE) 1996-06-11 US disclosed
US-5454862-A Starch product and urea mixture; restricted moisture content controls swelling COOPERATIEVE VERKOOP-EN PRODUCTIEVERENENIGING (NL) 1995-10-03 US disclosed
EP-0292495-B1 PHARMACEUTICAL COMPOSITIONS CONTAINING PROPYLENE GLYCOL AND/OR POLYETHYLENE GLYCOL AND UREA AS ACTIVE MAIN COMPONENTS MOBERG SVEN (SE) 1991-09-18 EP disclosed
EP-0292495-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING PROPYLENE GLYCOL AND/OR POLYETHYLENE GLYCOL AND UREA AS ACTIVE MAIN COMPONENTS. MOBERG SVEN (SE) 1988-11-30 EP disclosed
WO-1987004617-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING PROPYLENE GLYCOL AND/OR POLYETHYLENE GLYCOL AND UREA AS ACTIVE MAIN COMPONENTS AND USE THEREOF MOBERG SVEN (SE) 1987-08-13 WO disclosed